Jørgen de Jonge

1.7k total citations
27 papers, 757 citations indexed

About

Jørgen de Jonge is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Jørgen de Jonge has authored 27 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 12 papers in Molecular Biology and 11 papers in Infectious Diseases. Recurrent topics in Jørgen de Jonge's work include Influenza Virus Research Studies (14 papers), Viral gastroenteritis research and epidemiology (8 papers) and Respiratory viral infections research (5 papers). Jørgen de Jonge is often cited by papers focused on Influenza Virus Research Studies (14 papers), Viral gastroenteritis research and epidemiology (8 papers) and Respiratory viral infections research (5 papers). Jørgen de Jonge collaborates with scholars based in Netherlands, Russia and Canada. Jørgen de Jonge's co-authors include Anke Huckriede, Sietske K. Rosendahl Huber, Josine van Beek, Debbie van Baarle, Willem Luytjes, Jan Wilschut, Marijke Holtrop, Harry van Dijken, J Wilschut and J. Wilschut and has published in prestigious journals such as PLoS ONE, Advanced Drug Delivery Reviews and Journal of Virology.

In The Last Decade

Jørgen de Jonge

26 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jørgen de Jonge Netherlands 17 322 289 229 220 71 27 757
Lizhong Luo Canada 13 274 0.9× 218 0.8× 251 1.1× 166 0.8× 99 1.4× 24 710
Julie N. Reitter United States 15 374 1.2× 403 1.4× 341 1.5× 325 1.5× 99 1.4× 24 1.1k
Xianliang Ke China 18 526 1.6× 211 0.7× 401 1.8× 195 0.9× 64 0.9× 38 1.1k
Timo Frensing Germany 14 259 0.8× 396 1.4× 220 1.0× 164 0.7× 146 2.1× 19 728
Lonneke van der Linden Netherlands 16 397 1.2× 290 1.0× 305 1.3× 137 0.6× 115 1.6× 18 924
Gholamreza Ahmadian Iran 8 305 0.9× 124 0.4× 241 1.1× 138 0.6× 89 1.3× 10 662
Yali Qin China 16 355 1.1× 325 1.1× 250 1.1× 191 0.9× 66 0.9× 44 823
Scott Umlauf United States 13 379 1.2× 420 1.5× 149 0.7× 516 2.3× 107 1.5× 18 1.0k
Shuhei Taguwa Japan 15 524 1.6× 286 1.0× 345 1.5× 219 1.0× 116 1.6× 27 1.1k
Toyokazu Ishikawa Japan 19 204 0.6× 397 1.4× 206 0.9× 181 0.8× 24 0.3× 37 851

Countries citing papers authored by Jørgen de Jonge

Since Specialization
Citations

This map shows the geographic impact of Jørgen de Jonge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jørgen de Jonge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jørgen de Jonge more than expected).

Fields of papers citing papers by Jørgen de Jonge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jørgen de Jonge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jørgen de Jonge. The network helps show where Jørgen de Jonge may publish in the future.

Co-authorship network of co-authors of Jørgen de Jonge

This figure shows the co-authorship network connecting the top 25 collaborators of Jørgen de Jonge. A scholar is included among the top collaborators of Jørgen de Jonge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jørgen de Jonge. Jørgen de Jonge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dijken, Harry van, et al.. (2023). Modified influenza M158–66 peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge. npj Vaccines. 8(1). 116–116. 2 indexed citations
3.
Dijken, Harry van, Hiromi Muramatsu, Mitchell Beattie, et al.. (2022). A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets. Science Advances. 8(50). eadc9937–eadc9937. 27 indexed citations
4.
Dijken, Harry van, et al.. (2022). Influenza Infection in Ferrets with SARS-CoV-2 Infection History. Microbiology Spectrum. 10(6). e0138622–e0138622. 3 indexed citations
5.
Dijken, Harry van, Lisa Wijsman, Jolanda Kool, et al.. (2021). Pathology and Immunity After SARS-CoV-2 Infection in Male Ferrets Is Affected by Age and Inoculation Route. Frontiers in Immunology. 12. 750229–750229. 23 indexed citations
6.
Sadremomtaz, Afsaneh, Angel J. Ruiz‐Moreno, Alessandra Monti, et al.. (2021). Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein. Journal of Medicinal Chemistry. 65(4). 2836–2847. 27 indexed citations
7.
Dijken, Harry van, et al.. (2020). Systemic and respiratory T-cells induced by seasonal H1N1 influenza protect against pandemic H2N2 in ferrets. Communications Biology. 3(1). 564–564. 13 indexed citations
8.
Jonge, Jørgen de, Harry van Dijken, Sanne Spijkers, et al.. (2020). H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets. npj Vaccines. 5(1). 38–38. 21 indexed citations
9.
Soema, Peter C., Sietske K. Rosendahl Huber, Ronald Jacobi, et al.. (2018). Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8+ T Cell Epitopes. Frontiers in Immunology. 9. 525–525. 11 indexed citations
10.
Jonge, Jørgen de, Irina Isakova–Sivak, Harry van Dijken, et al.. (2016). H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets. Molecular Therapy. 24(5). 991–1002. 28 indexed citations
11.
Huber, Sietske K. Rosendahl, Marcel Camps, Ronald Jacobi, et al.. (2015). Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets. PLoS ONE. 10(6). e0127969–e0127969. 32 indexed citations
12.
Huber, Sietske K. Rosendahl, Josine van Beek, Jørgen de Jonge, Willem Luytjes, & Debbie van Baarle. (2014). T Cell Responses to Viral Infections – Opportunities for Peptide Vaccination. Frontiers in Immunology. 5. 171–171. 158 indexed citations
13.
van, Cécile A. C. M., Siri Mjaaland, Lisbeth Meyer Næss, et al.. (2014). Fast vaccine design and development based on correlates of protection (COPs): Influenza as a trendsetter. Human Vaccines & Immunotherapeutics. 10(7). 1935–1948. 16 indexed citations
14.
15.
Jonge, Jørgen de, Jean‐Pierre Amorij, Wouter L.J. Hinrichs, et al.. (2007). Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage. European Journal of Pharmaceutical Sciences. 32(1). 33–44. 43 indexed citations
16.
Wilschut, Jan, Jørgen de Jonge, Anke Huckriede, et al.. (2007). Preservation of Influenza Virosome Structure and Function During Freeze-Drying and Storage. Journal of Liposome Research. 17(3-4). 173–182. 11 indexed citations
17.
Huckriede, Anke, Jørgen de Jonge, Marijke Holtrop, & Jan Wilschut. (2007). Cellular Delivery of siRNA Mediated by Fusion-Active Virosomes. Journal of Liposome Research. 17(1). 39–47. 15 indexed citations
18.
Jonge, Jørgen de, et al.. (2006). Use of a dialyzable short-chain phospholipid for efficient solubilization and reconstitution of influenza virus envelopes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1758(4). 527–536. 26 indexed citations
19.
Jonge, Jørgen de, Marijke Holtrop, J Wilschut, & Anke Huckriede. (2005). Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs. Gene Therapy. 13(5). 400–411. 55 indexed citations
20.
Daemen, Toos, et al.. (2004). Virosomes for antigen and DNA delivery. Advanced Drug Delivery Reviews. 57(3). 451–463. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lizhong Luo Breakdown of academic impact, for papers by Julie N. Reitter Breakdown of academic impact, for papers by Xianliang Ke Breakdown of academic impact, for papers by Timo Frensing Breakdown of academic impact, for papers by Lonneke van der Linden Breakdown of academic impact, for papers by Gholamreza Ahmadian Breakdown of academic impact, for papers by Yali Qin Breakdown of academic impact, for papers by Scott Umlauf Breakdown of academic impact, for papers by Shuhei Taguwa Breakdown of academic impact, for papers by Toyokazu Ishikawa
Rankless by CCL
2026